- Gastric Cancer
The incidence of a certain type of gastric cancer has declined in the last 30 years for all age groups and races, except for whites 25 to 39 years of age, according to a study in the May 5 issue of JAMA. Another report in this issue, based on analysis of previous studies, finds that patients who receive chemotherapy after surgery for gastric cancer have a higher rate of survival compared to those patients who have surgery alone.
Gastric cancer is the fourth most common type of cancer and the second most com¬mon among cancer deaths worldwide. While tumors of the cardia, the upper part of the stomach adjoin¬ing the esophagus, may be related to gas¬troesophageal reflux, the majority of noncardia gastric cancers are attribut¬able to chronic mucosal infection by the bacterium Helicobacter pylori, according to background information in a study by William R. Anderson, M.D., of the National Cancer Institute, Rockville, Md., and colleagues.
“Overall, gastric cancer incidence has steadily declined in many countries over the past 50 years or longer. However, overall trends may mask important age- specific differences. Furthermore, the overall decline runs counter to the subsite-specific rise in cardia cancers that may be related to obesity and gastroesophageal reflux,” the authors write.
The researchers ana¬lyzed U.S. population-based age-specific data for noncardia gastric cancer, using data from the National Cancer Institute's Surveillance, Epi¬demiology, and End Results Program, which covers approximately 26 percent of the U.S. popu¬lation. From 1977 through 2006, there were 83,225 adults with new primary gastric cancer, including 39,003 noncardia cases.
The authors found that the overall age-standardized annual incidence per 100,000 population de¬clined during the study period from 5.9 to 4.0 in whites, from 13.7 to 9.5 in blacks, and from 17.8 to 11.7 in other races. “Age-specific trends among whites varied significantly between older and younger age groups: incidence per 100,000 declined significantly from 19.8 to 12.8 for ages 60 to 84 years and from 2.6 to 2.0 for ages 40 to 59 years but increased significantly from 0.27 to 0.45 for ages 25 to 39 years. Conversely, rates for all age groups declined or were stable among blacks and other races. Age-period-cohort analysis confirmed a signifi¬cant increase in whites among younger cohorts born since 1952.”
“Targeting all cancer cases in residents of defined geographic areas, the large-scale SEER database is broadly repre¬sentative of cancer incidence in the United States as a whole. Further age-specific analyses of noncardia gastric cancer incidence trends for low-risk populations will be informative,” the authors conclude.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.